Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Co-Administered IDA and Azithromycin
NCT03664063Phase 2Completed
- Sponsor
- Lihir Medical Centre
- Start
- Sep 2018
- Primary completion
- Oct 2018
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azithromycin, albendazole, ivermectin, diethylcarbamazine in lymphatic filariasis (LF), yaws, sponsored by Lihir Medical Centre. Started Sep 2018; status: completed.
02
Drugs
azithromycinalbendazoleivermectindiethylcarbamazine
03
Conditions
lymphatic filariasis (LF)yaws
Beyond the preview
Go deeper on NCT03664063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03664063.